Updated
Updated · UW Medicine Newsroom · Aug 20
Harborview Halted 29-Case C. auris Outbreak With 11,639 Tests and Universal PCR Screening
Updated
Updated · UW Medicine Newsroom · Aug 20

Harborview Halted 29-Case C. auris Outbreak With 11,639 Tests and Universal PCR Screening

1 articles · Updated · UW Medicine Newsroom · Aug 20

Summary

  • Harborview Medical Center contained a C. auris outbreak after a 23-week campaign that found 29 colonized patients, with none developing symptomatic infection or needing antifungal treatment.
  • 11,639 tests on 5,563 patients underpinned the effort as the Seattle hospital expanded from targeted checks to admission-wide and weekly screening, then cut turnaround to 20 hours with an in-house PCR test.
  • Strict infection controls reinforced the screening: positive patients were moved to single rooms, staff used gowns and gloves, and rooms were cleaned twice with bleach and twice with ultraviolet light, with ATP checks triggering recleaning.
  • Half of patients who acquired colonization in the hospital had occupied bed spaces previously used by colonized patients, highlighting environmental spread in a 500-bed facility with many shared rooms and high-risk patients.
  • C. auris has spread to 41 U.S. states since 2016 and caused more than 20,000 cases, including over 3,400 this year; invasive infections have been linked to death rates above 30%.

Insights

If this drug-resistant yeast survives for weeks on surfaces, what hidden dangers lurk in hospitals lacking rapid PCR testing?
With a deadly fungus evolving new ways to resist drugs, can universal hospital screening truly stop the next silent outbreak?
Could targeting a simple potassium transporter finally disarm a superbug that kills up to 60 percent of its vulnerable victims?